The Manufacturers Life Insurance Company Trims Stock Position in Select Medical Holdings Corporation $SEM

Key Points

• The Manufacturers Life Insurance Company reduced its stake in Select Medical Holdings by 11.2%, selling 178,965 shares during the first quarter, while holding 1.10% of the company valued at approximately $23.67 million.
• Select Medical reported an earnings per share (EPS) of $0.32 for the last quarter, surpassing estimates, with a revenue of $1.34 billion and a year-over-year revenue increase of 4.5%.
• The company has declared a quarterly dividend of $0.0625 per share, resulting in an annualized yield of 1.9%, with a payout ratio of 23.58%.

The Manufacturers Life Insurance Company decreased its holdings in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 11.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,417,449 shares of the health services provider's stock after selling 178,965 shares during the quarter. The Manufacturers Life Insurance Company owned 1.10% of Select Medical worth $23,671,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in SEM. Northern Trust Corp lifted its stake in Select Medical by 12.9% in the fourth quarter. Northern Trust Corp now owns 1,352,046 shares of the health services provider's stock worth $25,486,000 after acquiring an additional 153,992 shares during the last quarter. Schonfeld Strategic Advisors LLC purchased a new position in Select Medical in the fourth quarter worth approximately $889,000. Comerica Bank lifted its stake in Select Medical by 19.0% in the fourth quarter. Comerica Bank now owns 75,408 shares of the health services provider's stock worth $1,421,000 after acquiring an additional 12,020 shares during the last quarter. AXA S.A. purchased a new stake in Select Medical during the fourth quarter worth approximately $559,000. Finally, BNP Paribas Financial Markets lifted its stake in Select Medical by 1,965.5% during the fourth quarter. BNP Paribas Financial Markets now owns 551,912 shares of the health services provider's stock worth $10,404,000 after purchasing an additional 525,192 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company's stock.

Select Medical Stock Performance

SEM traded up $0.08 on Monday, hitting $13.18. 103,372 shares of the company traded hands, compared to its average volume of 1,119,380. The company has a 50 day moving average of $13.65 and a 200-day moving average of $15.27. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92. The stock has a market capitalization of $1.63 billion, a PE ratio of 12.40, a PEG ratio of 0.54 and a beta of 1.25. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The firm's revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.60 EPS. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Sell-side analysts anticipate that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were issued a $0.0625 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.25 dividend on an annualized basis and a yield of 1.9%. Select Medical's dividend payout ratio (DPR) is 23.58%.

Analyst Upgrades and Downgrades

Separately, UBS Group restated a "neutral" rating and set a $14.00 target price (down previously from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $20.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.